The report analyzes and
presents an overview of "
Acne Vulgaris Global Clinical Trials Review, H1, 2016 "
worldwide.
GlobalData's
clinical trial report, Acne
Vulgaris Global
Clinical Trials Review, H1, 2016" provides an overview of Acne
Vulgaris clinical trials scenario. This report provides top line data
relating to the clinical trials on Acne Vulgaris. Report includes an
overview of trial numbers and their average enrollment in top
countries conducted across the globe. The report offers coverage of
disease clinical trials by region, country (G7 & E7), phase,
trial status, end points status and sponsor type. Report also
provides prominent drugs for in-progress trials (based on number of
ongoing trials). GlobalData Clinical Trial Reports are generated
using GlobalDatas proprietary database - Pharma eTrack Clinical
trials database. Clinical trials are collated from 80+ different
clinical trial registries, conferences, journals, news etc across the
globe. Clinical trials database undergoes periodic update by dynamic
process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
Download
Sample copy of this Report at
Scope
- The report provides a
snapshot of the global clinical trials landscape
- Report provides top level
data related to the clinical trials by Region, Country (G7 & E7),
Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top
companies involved and enlists all trials (Trial title, Phase, and
Status) pertaining to the company
- The report provides all the
unaccomplished trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment
- The Report provides
enrollment trends for the past five years
- Report provides latest news
for the past three months
Reasons to buy
- Assists in formulating key
business strategies with regards to investment
- Helps in identifying
prominent locations for conducting clinical trials which saves time
and cost
- Provides top level analysis
of Global Clinical Trials Market which helps in identifying key
business opportunities
- Supports understanding of
trials count and enrollment trends by country in global therapeutics
market
- Aids in interpreting the
success rates of clinical trials by providing a comparative scenario
of completed and uncompleted (terminated, suspended or withdrawn)
trials
- Facilitates clinical trial
assessment of the indication on a global, regional and country level
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Countries Contributing to Clinical Trials in Middle East and Africa
13
Top
Five Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Acne Vulgaris to Dermatology
Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Acne Vulgaris to Dermatology
Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Acne Vulgaris Therapeutics Clinical Trials
28
Prominent
Drugs 30
Latest
Clinical Trials News on Acne Vulgaris 31
Mar
03, 2016: BioPharmX commences Phase 2 clinical study under U.S. FDA
IND for BPX-01 31
Mar
01, 2016: Novan Phase 2b Results with SB204 to be Presented at
American Academy of Dermatology 31
Feb
23, 2016: Novan Announces First Patient Dosed in Phase 3 Program for
SB204 31
Feb
15, 2016: Visonac Data Were Presented at The Euro PDT Congress in
Barcelona February 13th 32
Feb
10, 2016: Xenon Initiates Phase 2 Clinical Trial of XEN801 to Treat
Moderate to Severe Acne 32
Clinical
Trial Profile Snapshots 34
Appendix
300
Abbreviations
300
Definitions
300
Research
Methodology 301
Secondary
Research 301
About
GlobalData 302
Contact
Us 302
Disclaimer
302
Source
303
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment